STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Healthy
- STSA-1002 injection
- Placebo
- Overland Park, KansasAltaSciences Clinical Kansas, Inc
2022-01-25
Jan 25, 2022H
Recruiting
- Spinal Fusion
- Abaloparatide
- Placebo
- New York, New YorkHospital for Special Surgery
2022-03-29
Mar 29, 2022D
Completed
- Dry Eye Syndromes
- Single dose of rhEGF 10mcg/ml or placebo
- +5 more
- Seongnam-si, Korea, Republic ofSeoul National University Bundang Hospital
2022-01-27
Jan 27, 2022U
Completed
- Analgesia
- Cold Pressor Test (CPT)
- Placebo NaCl Nasal spray
- Basel, Basel-Stadt, SwitzerlandUniversitäts-Kinderspital beider Basel (UKBB)
2022-03-14
Mar 14, 2022U
Not yet recruiting
- Cocaine Use Disorder
- Extended-Release Naltrexone
- +2 more
- (no location specified)
2022-03-01
Mar 1, 2022B
Completed
- Spine Surgery
- open label placebo
- Boston, MassachusettsBrigham and Women's Hospital
2021-09-09
Sep 9, 2021N
Not yet recruiting
- Alcohol Use Disorder
- Donepezil + Cognitive remediation therapy (CRT)
- +3 more
- (no location specified)
2021-09-03
Sep 3, 2021O
L
Completed
- Pain
- Itch
- Placebo induction
- +2 more
- Leiden, South Holland, NetherlandsLeiden University
2022-01-10
Jan 10, 2022O
Completed
- Hypercholesterolemia
- ezetimibe with simvastatin
- +2 more
- (no location specified)
2022-02-07
Feb 7, 2022S
Recruiting
- Healthy
- STSA-1002 injection
- Placebo
- Hefei, Anhui, China
- +3 more
2022-01-12
Jan 12, 2022D
M
Not yet recruiting
- Adrenal Insufficiency
- Hydrocortisone
- Placebo
- (no location specified)
2022-02-04
Feb 4, 2022H
Recruiting
- Threatened Miscarriage
- Chinese Herbal Medicine plus Progesterone Capsules
- +3 more
- Shenzhen, Guangdong, China
- +8 more
2021-09-22
Sep 22, 2021V
Completed
- Healthy Subjects
- VV116 25mg Group
- +4 more
- Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
2022-01-26
Jan 26, 2022U
Recruiting
- Overweight and Obesity
- PreDiabetes
- Appethyl®
- Placebo
- Frederiksberg, DK, DenmarkUniversity of Copenhagen
2022-02-11
Feb 11, 2022O
Completed
- Rhinitis, Allergic, Seasonal
- Mometasone furoate
- +3 more
- (no location specified)
2022-02-07
Feb 7, 2022P
Recruiting
- Healthy
- Bentracimab (PB2452) 100 mg or Placebo
- +6 more
- Tongzhou, Beijing, ChinaBeijing Friendship Hospital
2022-02-04
Feb 4, 2022N
O
Completed
- Asthma
- montelukast sodium
- +2 more
- (no location specified)
2022-01-31
Jan 31, 2022O
Completed
- Asthma, Exercise-Induced
- Comparator: Montelukast
- +3 more
- (no location specified)
2022-01-31
Jan 31, 2022C
Not yet recruiting
- Anxiety
- Pancreatic Cancer
- Ketamine
- Placebo
- Los Angeles, CaliforniaCedars-Sinai Medical Center
2022-01-25
Jan 25, 2022S
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- HM201
- Placebo
- (no location specified)
2021-10-12
Oct 12, 2021N
Recruiting
- Normal Physiology
- Oral Methylphenidate followed by IV placebo
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022C
Not yet recruiting
- Stress Urinary Incontinence
- AMDC-USR
- Placebo
- (no location specified)
2022-02-16
Feb 16, 2022